Merck, Glenmark Can't Shake Zetia Pay-For-Delay MDL
Drugmakers Merck & Co Inc. and Glenmark Pharmaceuticals Ltd. lost a bid to kill multidistrict litigation alleging a pay-for-delay scheme involving the cholesterol medication Zetia when a Virginia federal judge on...To view the full article, register now.
Already a subscriber? Click here to view full article